7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine

C141H120F11N49O9S2 — CID 157182643

About 7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine

7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine (PubChem CID 157182643) has the molecular formula C141H120F11N49O9S2 and a molecular weight of 2917.96 g/mol. Its IUPAC name is 7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine.

Molecular Properties

• Compound Name: 7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine
• PubChem CID: 157182643
• Molecular Formula: C141H120F11N49O9S2
• Molecular Weight: 2917.96 g/mol
• Exact Mass: 2915.97
• IUPAC Name: 7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine
• SMILES: COCCOc1cnc2c(NCc3nnc4ccc(-c5cc(C)ns5)nn34)ccnc2c1.Cc1cc(-c2ccc3nnc(CNc4ccnc5cc(OC(F)F)cnc45)n3n2)sn1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCCN6CCCC6)cnc45)n3n2)c1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCCN6CC[C@H](F)C6)cnc45)n3n2)c1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCCn6ccnn6)cnc45)n3n2)c1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OC[C@@H]6COCCO6)cnc45)n3n2)c1
• InChI: InChI=1S/C26H23F3N8O.C26H24F2N8O.C25H21F2N7O3.C24H18F2N10O.C21H20N8O2S.C19H14F2N8OS/c27-17-4-6-36(15-17)7-8-38-20-12-23-26(32-13-20)22(3-5-30-23)31-14-25-34-33-24-2-1-21(35-37(24)25)16-9-18(28)11-19(29)10-16;27-18-11-17(12-19(28)13-18)21-3-4-24-32-33-25(36(24)34-21)16-30-22-5-6-29-23-14-20(15-31-26(22)23)37-10-9-35-7-1-2-8-35;26-16-7-15(8-17(27)9-16)20-1-2-23-31-32-24(34(23)33-20)12-29-21-3-4-28-22-10-18(11-30-25(21)22)37-14-19-13-35-5-6-36-19;25-16-9-15(10-17(26)11-16)19-1-2-22-31-32-23(36(22)33-19)14-28-20-3-4-27-21-12-18(13-29-24(20)21)37-8-7-35-6-5-30-34-35;1-13-9-18(32-28-13)15-3-4-19-25-26-20(29(19)27-15)12-23-16-5-6-22-17-10-14(11-24-21(16)17)31-8-7-30-2;1-10-6-15(31-28-10)12-2-3-16-25-26-17(29(16)27-12)9-23-13-4-5-22-14-7-11(30-19(20)21)8-24-18(13)14/h1-3,5,9-13,17H,4,6-8,14-15H2,(H,30,31);3-6,11-15H,1-2,7-10,16H2,(H,29,30);1-4,7-11,19H,5-6,12-14H2,(H,28,29);1-6,9-13H,7-8,14H2,(H,27,28);3-6,9-11H,7-8,12H2,1-2H3,(H,22,23);2-8,19H,9H2,1H3,(H,22,23)/t17-;;19-;;;/m0.0.../s1
• InChIKey: AOSZKPGEYIOAAM-XRKVMKEKSA-N
• XLogP: 21.71
• TPSA: 631.38 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 60
• Rotatable Bonds: 45
• Heavy Atoms: 212
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2917.96
LogP ≤ 5	21.71
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	60

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine?

The IUPAC name of 7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine (CID 157182643) is 7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine.

What is the SMILES notation for 7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine?

The canonical SMILES for 7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine is COCCOc1cnc2c(NCc3nnc4ccc(-c5cc(C)ns5)nn34)ccnc2c1.Cc1cc(-c2ccc3nnc(CNc4ccnc5cc(OC(F)F)cnc45)n3n2)sn1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCCN6CCCC6)cnc45)n3n2)c1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCCN6CC[C@H](F)C6)cnc45)n3n2)c1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCCn6ccnn6)cnc45)n3n2)c1.Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OC[C@@H]6COCCO6)cnc45)n3n2)c1.

What is the InChIKey of 7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine?

The InChIKey is AOSZKPGEYIOAAM-XRKVMKEKSA-N. The full InChI is InChI=1S/C26H23F3N8O.C26H24F2N8O.C25H21F2N7O3.C24H18F2N10O.C21H20N8O2S.C19H14F2N8OS/c27-17-4-6-36(15-17)7-8-38-20-12-23-26(32-13-20)22(3-5-30-23)31-14-25-34-33-24-2-1-21(35-37(24)25)16-9-18(28)11-19(29)10-16;27-18-11-17(12-19(28)13-18)21-3-4-24-32-33-25(36(24)34-21)16-30-22-5-6-29-23-14-20(15-31-26(22)23)37-10-9-35-7-1-2-8-35;26-16-7-15(8-17(27)9-16)20-1-2-23-31-32-24(34(23)33-20)12-29-21-3-4-28-22-10-18(11-30-25(21)22)37-14-19-13-35-5-6-36-19;25-16-9-15(10-17(26)11-16)19-1-2-22-31-32-23(36(22)33-19)14-28-20-3-4-27-21-12-18(13-29-24(20)21)37-8-7-35-6-5-30-34-35;1-13-9-18(32-28-13)15-3-4-19-25-26-20(29(19)27-15)12-23-16-5-6-22-17-10-14(11-24-21(16)17)31-8-7-30-2;1-10-6-15(31-28-10)12-2-3-16-25-26-17(29(16)27-12)9-23-13-4-5-22-14-7-11(30-19(20)21)8-24-18(13)14/h1-3,5,9-13,17H,4,6-8,14-15H2,(H,30,31);3-6,11-15H,1-2,7-10,16H2,(H,29,30);1-4,7-11,19H,5-6,12-14H2,(H,28,29);1-6,9-13H,7-8,14H2,(H,27,28);3-6,9-11H,7-8,12H2,1-2H3,(H,22,23);2-8,19H,9H2,1H3,(H,22,23)/t17-;;19-;;;/m0.0.../s1.

What are the key properties of 7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine?

7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine has a molecular weight of 2917.96 g/mol, XLogP of 21.71, 45 rotatable bonds, 6 hydrogen bond donors, and 60 hydrogen bond acceptors.

Where does this data come from?

All data for 7-(difluoromethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[[(2S)-1,4-dioxan-2-yl]methoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-(2-pyrrolidin-1-ylethoxy)-1,5-naphthyridin-4-amine;N-[[6-(3,5-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-[2-(triazol-1-yl)ethoxy]-1,5-naphthyridin-4-amine;7-(2-methoxyethoxy)-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine is sourced from PubChem (CID 157182643), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).